Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Two young elephants at the Cincinnati Zoo, Sanjay and Kabir, overcame a deadly virus thanks to a new vaccine introduced to ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...

Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

Opioid addicts covered by Medicare and Medicaid are less likely to receive the mental health and substance use treatment that ...

The cellular action that enables the mouth's interior lining to heal quicky and without scarring has always been a mystery, ...